MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,826,000 | -6.6% | 240,927 | -10.2% | 0.02% | +14.3% |
| Q2 2022 | $18,011,000 | +133.0% | 268,300 | +185.4% | 0.02% | +133.3% |
| Q1 2022 | $7,729,000 | +14.2% | 94,000 | +124.3% | 0.01% | +12.5% |
| Q2 2021 | $6,769,000 | -56.0% | 41,907 | -53.4% | 0.01% | -57.9% |
| Q1 2021 | $15,400,000 | -61.9% | 89,900 | -51.2% | 0.02% | -56.8% |
| Q4 2020 | $40,436,000 | +405.3% | 184,100 | +196.5% | 0.04% | +633.3% |
| Q4 2019 | $8,002,000 | -71.1% | 62,100 | -82.6% | 0.01% | -73.9% |
| Q3 2019 | $27,728,000 | -40.0% | 355,900 | -20.7% | 0.02% | -43.9% |
| Q2 2019 | $46,247,000 | +1154.3% | 449,000 | +792.6% | 0.04% | +1266.7% |
| Q1 2019 | $3,687,000 | +123.5% | 50,300 | +29.3% | 0.00% | +50.0% |
| Q4 2018 | $1,650,000 | -64.0% | 38,900 | -60.0% | 0.00% | -60.0% |
| Q3 2018 | $4,578,000 | +1916.7% | 97,200 | +2013.0% | 0.01% | – |
| Q2 2018 | $227,000 | -73.4% | 4,600 | -97.2% | 0.00% | -100.0% |
| Q1 2017 | $854,000 | +21.0% | 164,302 | +53.8% | 0.00% | 0.0% |
| Q3 2016 | $706,000 | -45.1% | 106,800 | -54.7% | 0.00% | -50.0% |
| Q2 2016 | $1,287,000 | +83.6% | 235,720 | +886.3% | 0.00% | +100.0% |
| Q1 2015 | $701,000 | +75.2% | 23,900 | +13.8% | 0.00% | 0.0% |
| Q1 2014 | $400,000 | – | 21,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |